Combination of umbilical cord mesenchymal stem cells and standard immunosuppressive regimen for pediatric patients with severe aplastic anemia
Abstract Background Defects of bone marrow mesenchymal stem cells (BM-MSCs) in proliferation and differentiation are involved in the pathophysiology of aplastic anemia (AA). Infusion of umbilical cord mesenchymal stem cells (UC-MSCs) may improve the efficacy of immunosuppressive therapy (IST) in chi...
Saved in:
Main Authors: | Yang Lan (Author), Fang Liu (Author), Lixian Chang (Author), Lipeng Liu (Author), Yingchi Zhang (Author), Meihui Yi (Author), Yuli Cai (Author), Jing Feng (Author), Zhibo Han (Author), Zhongchao Han (Author), Xiaofan Zhu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aplastic anemia: immunosuppressive therapy in 2010
by: Antonio M. Risitano, et al.
Published: (2011) -
Umbilical Cord Blood-Derived Cells Can Reconstruct Hematopoiesis in an Aplastic Anemia Animal Model
by: Zesong Chen, et al.
Published: (2024) -
Outcome of immunosuppressive therapy in children with acquired aplastic anemia
by: Alaka Das, et al.
Published: (2024) -
Outcome of immunosuppressive therapy in children with acquired aplastic anemia
by: Alaka Das, et al.
Published: (2024) -
Efficacy of eltrombopag with immunosuppressive therapy for children with acquired aplastic anemia
by: Yufei Zhao, et al.
Published: (2023)